Transpek Industry Limited (TRANSPEK.BO)
- Previous Close
1,501.35 - Open
1,529.35 - Bid 1,532.60 x --
- Ask 1,545.00 x --
- Day's Range
1,460.00 - 1,558.00 - 52 Week Range
1,100.05 - 1,890.00 - Volume
40,536 - Avg. Volume
4,914 - Market Cap (intraday)
8.554B - Beta (5Y Monthly) -0.39
- PE Ratio (TTM)
24.34 - EPS (TTM)
62.91 - Earnings Date Aug 6, 2025 - Aug 11, 2025
- Forward Dividend & Yield 14.00 (0.93%)
- Ex-Dividend Date Sep 13, 2024
- 1y Target Est
--
Transpek Industry Limited manufactures and sells chemical products in India. It offers 2, 4, 6 trimethyl benzoyl chloride, 2-chloroethylamine hydrochloride solution, 2-ethylhexanoyl chloride, 2-methoxyethyl chloride, 2-propoxyethyl chloride, 4-chlorobutyryl chloride, cocoyl chloride, diethylene glycol dichloride, isobutyryl chloride, isononanoyl chloride, isophthaloyl chloride, and lauroyl chloride. The company also provides m-nitrobenzoyl chloride, methoxyacetyl chloride, n-butyryl chloride, n-decanoyl chloride, n-octyl chloride, n-valeroyl chloride, neodecanoyl chloride, o-toluoyl chloride, octanoyl chloride, p-nitrobenzoyl chloride, pivaloyl chloride, propargyl chloride solution, sulphur dichloride, sulphur monochloride, terephthaloyl chloride, triethyleneglycol dichloride, and thionyl chloride. It serves customers in various industries, such as textiles, pharmaceuticals, agrochemicals, advanced polymers, etc. The company also exports its products. Transpek Industry Limited was incorporated in 1965 and is headquartered in Vadodara, India.
www.transpek.comRecent News: TRANSPEK.BO
View MorePerformance Overview: TRANSPEK.BO
Trailing total returns as of 5/9/2025, which may include dividends or other distributions. Benchmark is S&P BSE SENSEX (^BSESN) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: TRANSPEK.BO
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: TRANSPEK.BO
View MoreValuation Measures
Market Cap
8.39B
Enterprise Value
8.81B
Trailing P/E
23.88
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
1.33
Price/Book (mrq)
1.06
Enterprise Value/Revenue
1.39
Enterprise Value/EBITDA
8.43
Financial Highlights
Profitability and Income Statement
Profit Margin
5.49%
Return on Assets (ttm)
--
Return on Equity (ttm)
--
Revenue (ttm)
6.4B
Net Income Avi to Common (ttm)
351.59M
Diluted EPS (ttm)
62.91
Balance Sheet and Cash Flow
Total Cash (mrq)
566.68M
Total Debt/Equity (mrq)
12.98%
Levered Free Cash Flow (ttm)
--